TPIV mov is ahead
TPIV200
Triple-negative breast cancer (TNBC) - second line
3Q 2018
09/30/2018
Phase 2 interim response data due 3Q 2018.
Triple-negative breast cancer (TNBC) - second line
3Q 2018
09/30/2018
Phase 2 interim response data due 3Q 2018.
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。